Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 20/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5428803 | 0.89 | OXTR (1.00) | OXTR | |
| SCHEMBL5422788 | 0.86 | OXTR (0.83) | OXTR | |
| SCHEMBL5420992 | 0.86 | OXTR (0.80) | OXTR | |
| SCHEMBL5419731 | 0.84 | OXTR (1.00) | OXTR | |
| SCHEMBL5423489 | 0.84 | OXTR (0.57) | OXTR | |
| SCHEMBL5426018 | 0.83 | OXTR (0.60) | OXTR | |
| SCHEMBL1598224 | 0.82 | OXTR (0.81) | OXTR | |
| SCHEMBL9975177 | 0.82 | OXTR (0.81) | OXTR | |
| SCHEMBL5483388 | 0.82 | OXTR (0.81) | OXTR | |
| SCHEMBL9975175 | 0.80 | OXTR (0.80) | OXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185162-A1 | Substituted diketopiperazines as oxytocin receptor antagonists | KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) | 2007-08-09 | — | — | US | disclosed |
| US-20070185162-A1 | Substituted diketopiperazines as oxytocin receptor antagonists | KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) | 2007-08-09 | — | — | US | disclosed |
| US-20070185162-A1 | Substituted diketopiperazines as oxytocin receptor antagonists | KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185162-A1 | Substituted diketopiperazines as oxytocin receptor antagonists | OXTR, AVPR2, PRLHR | OXTR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.